Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Risk Assessment generated by a regulatory process
(RA)
published: 27 Sep 2017
last updated: 29 Aug 2022
Risk assessment of transgenic clover
EN
24 Jul 2017
-
Competent National Authority:Ministry of Natural Resources and Environmental Protection of the Republic of Belarus ()10 Kollektornaya streetMinsk,
220048,Phone: +375 17 200-6691,Fax: +375 17 200-5583,Email: minproos@mail.belpak.by,
-
Person:Associate Professor Valentina Aleksandrovna LemeshHead of the Laboratory of Genetics and Cell Engineering, Laboratory of Genetic and Cell Engineering27 Akademicheskaya streetMinsk,
220072,Phone: +375 17 284-1943,Fax: +375 17 284-1917,Email: V.Lemesh@igc.bas-net.by,Website: http://gens.by, http://gens.by,Related OrganizationInstitute of Genetics and Cytology at the National Academy of Sciences of Belarus (IGC NASB)27 Akademicheskaya streetMinsk,
220072,Phone: +375 17 284-1943,Fax: +375 17 284-1917,Email: V.Lemesh@igc.bas-net.by,Website: http://gens.by, http://gens.by,
-
Red Clover modified for cold tolerance and fungal resistance| State Scientific Institution «Central Botanical Garden of the National Academy of Sciences of Belarus» | Resistance to antibiotics (Kanamycin), Resistance to diseases and pests (Fungi), Selectable marker genes and reporter genes, Tolerance to abiotic stress (Cold / Heat)
- Оценка риска Клевер.pdf [ English ]
EN
EN
EN
EN
EN
EN
EN
multiplex PCR
EN
The Expert Council on Safety of Genetically Engineered Organisms of the Ministry of Natural Resources and Environmental Protection of the Republic of Belarus, based on the conclusion of the State Safety Expertise, discussions, comments of the members of the Expert Council on the admissibility of release of transgenic red clover to the environment for confined field trials on the trial field adopted recommendations on the inadmissibility of the transgenic clover line release. The decision based on the need for a more comprehensive study of the possibility of DNA sequences horizontal transfer to nodule bacteria that are symbiotic with clover.
EN
| Record type | Field | Record(s) | |
|---|---|---|---|
| Country's Decision or any other Communication | Risk assessment | 1 | |
